Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
3.310
+0.160 (5.08%)
At close: May 13, 2025, 4:00 PM
3.310
0.00 (0.00%)
Pre-market: May 14, 2025, 4:45 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
Vonoprazan
55.25M
Log In
Vonoprazan Growth
8001.47%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
United States
55.25M
Log In
United States Growth
8001.47%
Log In